Clinical Trial Update: Use of Eylea for the Treatment of an Optic Nerve Hemangioma

View source ↗

Summary

A clinical trial evaluating Eylea (aflibercept) for retinal hemangioma is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinal Hemangioma

Drugs mentioned

• EYLEA (Aflibercept)

Snippet

Sponsor: Vitreous -Retina- Macula Consultants of New York | Conditions: Retinal Hemangioma | Status: NO_LONGER_AVAILABLE